BHV (BHV) Stock Price & Analysis
BHV (BHV) rose 0.00% to USD 12.4 as of June 9, 2026 at 23:45 UTC, according to Nexqual real-time market data.
BHV last closed at USD 12.4; the session ranged USD 12.4–12.4 on volume of 80 shares. Market capitalization is $19.70M, with a 52-week range of USD 10.01–12.63 (NYQ). Source: Nexqual, June 9, 2026 at 23:45 UTC.
Key Statistics (as of June 9, 2026 at 23:45 UTC)
| Price | USD 12.4 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 12.4 |
| Open | USD 12.4 |
| Day Range | USD 12.4 – 12.4 |
| 52-Week Range | USD 10.01 – 12.63 |
| Volume | 80 shares |
| Market Cap | $19.70M |
| Exchange | NYQ |
Technical Analysis (BHV)
Nexqual's technical model rates BHV "BUY" based on 5 bullish and 3 bearish signals across 123 daily candles, as of June 9, 2026 at 23:45 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 81.09 (overbought) |
| vs SMA50 | Above (USD 11.15) |
| MACD | 0.26 (positive) |
Analyst Ratings (BHV)
Wall Street analysts rate BHV "None", per Nexqual as of June 9, 2026 at 23:45 UTC.
| Consensus Rating | None |
|---|---|
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (BHV)
Source: Nexqual, June 9, 2026 at 23:45 UTC.
Financials & Fundamentals (BHV)
| Total Revenue | $1.39M |
|---|---|
| Revenue Growth (YoY) | -2.00% |
| Gross Margin | +100.00% |
| Operating Margin | +66.63% |
| Profit Margin | -1.92% |
| ROE | -0.14% |
| Debt / Equity | 63.3 |
| Current Ratio | 1.66 |
| Total Debt | $11.59M |
| Free Cash Flow | $502,477 |
Source: Nexqual, June 9, 2026 at 23:45 UTC.
Financial Health Score (BHV)
Nexqual rates BHV's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 23:45 UTC.
| Growth | Weak — Revenue -2% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — Debt/Equity 0.6x |
| Cash Flow | Strong — FCF $502K, 36% margin |
| Efficiency | Critical — ROE -0%, ROA 1.9% |
Ownership (BHV)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +6.04% |
| Shares Outstanding | 1.59M |
| Short % of Float | +0.32% |
Source: Nexqual, June 9, 2026 at 23:45 UTC.
Major Backers & Investors (BHV)
Notable institutional backers of BHV include Morgan Stanley, D'Orazio & Associates, Inc., Stifel Financial Corporation, according to Nexqual as of June 9, 2026 at 23:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 1.71% |
| D'Orazio & Associates, Inc. | 1.06% |
| Stifel Financial Corporation | 1.06% |
| RiverNorth Capital Management, LLC | 0.98% |
| Geneos Wealth Management, Inc. | 0.48% |
| UBS Group AG | 0.33% |
| Osaic Holdings Inc. | 0.26% |
| Steward Partners Investment Advisory, LLC | 0.13% |
Source: Nexqual, June 9, 2026 at 23:45 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CEV | 10525 | USD 10.27 | ▲ 0.29% |
| NPV | Nuveen Virginia Quality Municip | USD 11.51 | ▼ 0.09% |
| MPA | Blackrock MuniYield Pennsylvani | USD 11.31 | ▲ 0.44% |
| DTF | DTF Tax-Free Income, Inc. | USD 11.49 | ▲ 0.48% |
| MIY | Blackrock MuniYield Michigan Qu | USD 12.31 | ▲ 1.4% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:45 UTC. This page is informational and not investment advice.